Challenges in identifying high risk patients for preeclampsia using USPSTF guidelines

Challenges in identifying high risk patients for preeclampsia using USPSTF guidelines

Preeclampsia (PE) is a hypertensive disease that complicates 7-10% of pregnancies. While recent advances in understanding the underlying causes of PE have been made, predicting its occurrence has historically been difficult because it is a complex condition that likely results from a variety of causes and can present in different ways.

Q&A: Evaluating the effectiveness of guidelines to predict the risk of preeclampsia

Thomas McElrath, MD, Ph.D., of the Department of Obstetrics & Gynecology at Brigham & Women's Hospital, is the lead and corresponding author of a paper published in JAMA Network Open, "Utility of the US Preventive Services Task Force for Preeclampsia Risk Assessment and Aspirin Prophylaxis."

National guidelines for assessing preeclampsia risk are ineffective, study finds

New study finds U.S. preeclampsia guidelines lead to a high rate of false positives, prompting unnecessary treatment — and a call for reform.

New Study in JAMA Network Open Shows Current Approaches to Assessing Preeclampsia Risk Are Failing the Majority of Pregnant Moms

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jul 17, 2025-

Thomas McElrath, MD, PhD, highlights limitations of current preeclampsia guidelines

New research reveals that existing USPSTF guidelines may overgeneralize preeclampsia risk, highlighting the need for biologically based, personalized screening methods to improve maternal outcomes.